Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.
J E Starrett, D R Tortolani, M J Hitchcock, J C Martin, M M Mansuri
文献索引:Antiviral Res. 19(3) , 267-73, (1992)
全文:HTML全文
摘要
9-(2-Phosphonylmethoxyethyl)adenine (PMEA; 1) was acylated with chloromethyl pivalate to afford bis(pivaloyloxymethyl) PMEA (2). The ester prodrug demonstrated enhanced in vitro potency against HSV-2 greater than 150-fold higher than the parent compound. The antiviral activity of 2 was 50-fold better than PMEA against HSV-1, and equipotent against HIV and HCMV. The toxicity of 2 was studied in both resting and growing cells.
相关化合物
相关文献:
2013-11-01
[Synthesis 44(16) , doi:10.1055/s-0031-1289791, (2012)]
2000-02-01
[Il Farmaco 55(2) , 134-5, (2000)]
1993-06-01
[Biol. Pharm. Bull. 16(6) , 594-9, (1993)]